TREATMENT OF ADULT ALL ACCORDING TO PROTOCOLS OF THE GERMAN MULTICENTER STUDY GROUP FOR ADULT ALL (GMALL)

This publication has 17 references indexed in Scilit:

• Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction
  Bone Marrow Transplantation, 2000
• Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study
  Leukemia, 1999
• Improved treatment outcome in adult acute lymphoblastic leukemia using the intensive German protocol, a preliminary report
  Hematological Oncology, 1997
• Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia
  Blood, 1994
• 2 Immunophenotypic classification of acute lymphoblastic leukaemia
  Bailliere's Clinical Haematology, 1994
• In patients with BCR-ABL-positive ALL in CR peripheral blood contains less residual disease than bone marrow: Implications for autologous BMT
  Annals of Hematology, 1994
• Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction
  The Lancet, 1991
• Improved results of an intensified therapy in adult acute lymphocytic leukemia
  Annals of Oncology, 1991
• Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults
  Blood, 1988
• Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults
  Blood, 1984